Issue Information
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 28, 2023 Category: Allergy & Immunology Tags: ISSUE INFORMATION Source Type: research

Readability and quality analysis of patient education materials in aspirin exacerbated respiratory disease
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 27, 2023 Category: Allergy & Immunology Authors: Kush Panara, Elysia Grose, Daniel J Lee, Jenelle Safadi, Jennifer E Douglas, Michael A Kohanski, James N Palmer, John M Lee, Nithin D Adappa, John V Bosso Tags: CLINICAL LETTER Source Type: research

Local Cytokine Levels Associate with SNOT ‐22 and UPSIT Scores in Chronic Rhinosinusitis
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 27, 2023 Category: Allergy & Immunology Authors: Sophie E. Yu, Simon Chiang, Tolani F. Olonisakin, John A. Moore, Regan W. Bergmark, Alice Z. Maxfield, Rachel E. Roditi, Kathleen M. Buchheit, Marie Lundberg, Margaret B. Mitchell, Stella E. Lee Tags: RESEARCH NOTE Source Type: research

Endoscopic endonasal recanalization of the obliterated eustachian tube via ureteral stent
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 27, 2023 Category: Allergy & Immunology Authors: Christopher Pool, George Liu, Frederick Yoo, Rohit Garg, David Keschner Tags: CLINICAL LETTER Source Type: research

Risk factors associated with recurrent acute rhinosinusitis
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 27, 2023 Category: Allergy & Immunology Authors: John Behnke, Zayd Al Asadi, Dominic Lombardo, Ruifeng Cui, Hassan H. Ramadan, Chadi A. Makary Tags: CLINICAL LETTER Source Type: research

Real ‐world effectiveness of mepolizumab in severe asthma and chronic rhinosinusitis (CRS) in the US: Impact of comorbidity and sinus surgery
ConclusionsConsistent with trial data, mepolizumab use in real-world practice shows benefits across comorbid patient cohorts with more pronounced impact in those with severe asthma+comorbid CRS+sinus surgery.This article is protected by copyright. All rights reserved (Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 27, 2023 Category: Allergy & Immunology Authors: Jared Silver, Arijita Deb, Fran çois Laliberté, Chi Gao, Neil Bhattacharyya Tags: ORIGINAL ARTICLE Source Type: research

Inappropriate image duplications in rhinology research publications
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 26, 2023 Category: Allergy & Immunology Authors: Do ‐Yeon Cho, Jessica Bishop, Jessica Grayson, Bradford A. Woodworth Tags: RESEARCH NOTE Source Type: research

Air pollution exposure is associated with rhinitis in older US adults via specific immune mechanisms
ConclusionWe show for the first time that IL-3, IL-12, and IFN- γ explain in part the relationship between PM2.5 exposure on rhinitis in older US adults. If confirmed, these immune pathways may be used as therapeutic targets.This article is protected by copyright. All rights reserved (Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 26, 2023 Category: Allergy & Immunology Authors: Henrique Ochoa Scussiatto, Kristen E. Wroblewski, Kristina L. Pagel, L. Phillip Schumm, Martha K. McClintock, Murray Ramanathan, Helen H. Suh, Jayant M. Pinto Tags: ORIGINAL ARTICLE Source Type: research

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24 ‐week treatment‐free follow‐up
Conclusion52 weeks of mepolizumab treatment is associated with sustained clinical benefits up to 24 weeks after discontinuation in patients with severe CRSwNP, which should be considered by physicians when making treatment decisions.This article is protected by copyright. All rights reserved (Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 23, 2023 Category: Allergy & Immunology Authors: Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, Peter W Hellings, Joseph K Han, Anju T Peters, Jared Silver, Steven G Smith, Abigail Fuller, Ana R Sousa, Robert H Chan, Philippe Gevaert Tags: ORIGINAL ARTICLE Source Type: research

Increase in the prevalence of follicular regulatory T cells correlates with clinical efficacy of sublingual immunotherapy with house dust mites
CONCLUSIONAn increase in Tfr cells may play an important role in SLIT, and may be a useful indicator for the clinical efficacy of SLIT.This article is protected by copyright. All rights reserved (Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 22, 2023 Category: Allergy & Immunology Authors: Takuya Murao, Hideaki Kouzaki, Hiroyuki Arai, Koji Matsumoto, Keigo Nakamura, Kento Kawakita, Ichiro Tojima, Shino Shimizu, Atsushi Yuta, Takeshi Shimizu Tags: ORIGINAL ARTICLE Source Type: research

Clinical characteristics analysis of sinonasal diffuse large b ‐cell lymphoma and extranodal nk/t‐cell lymphoma
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 18, 2023 Category: Allergy & Immunology Authors: Hye ‐Bin Jang, Dong Hoon Lee, Ga‐Young Song, Deok‐Hwan Yang, Sang Chul Lim Tags: CLINICAL LETTER Source Type: research

Not just snot: local inflammatory profiles in aerd patients differ from non ‐aerd chronic rhinosinusitis
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 16, 2023 Category: Allergy & Immunology Authors: Simon Chiang, Sophie E. Yu, Tejas S Athni, Regan W Bergmark, Alice Z Maxfield, Rachel E Roditi, Kathleen M Buchheit, Marie Lundberg, Margaret B Mitchell, Stella E Lee Tags: RESEARCH NOTE Source Type: research

Depression, Anxiety, and Suicidal Ideation in adults with COVID ‐induced Parosmia
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 16, 2023 Category: Allergy & Immunology Authors: Emily Stoller, Firas Hentati, Dorina Kallogjeri, Jay F. Piccirillo, Eric J. Lenze, Nyssa Fox Farrell Tags: RESEARCH NOTE Source Type: research

Mir ‐200a‐3p regulates epithelial‐mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting zeb1 via erk/p38 pathway
ConclusionsMiR-200a-3p suppresses EMT and inflammation by regulating the expression of ZEB1 via the ERK/P38 pathway. Our study provides new ideas for protecting nasal epithelial cells from tissue remodeling and finding a possible target for disease.This article is protected by copyright. All rights reserved (Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 15, 2023 Category: Allergy & Immunology Authors: Yisha Wu, Kaiyue Sun, Yanyi Tu, Ping Li, Dingqian Hao, Peng Yu, Aiping Chen, Yuzhu Wan, Li Shi Tags: ORIGINAL ARTICLE Source Type: research

Pembrolizumab ‐Associated Chronic Rhinosinusitis: A new endotype and management considerations
(Source: International Forum of Allergy and Rhinology)
Source: International Forum of Allergy and Rhinology - June 15, 2023 Category: Allergy & Immunology Authors: Taylor Standiford, Neil N Patel, Amritpal Singh, Grant Gochman, Tara Jamie Wu, Adil I Daud, Andrew N Goldberg Tags: RESEARCH NOTE Source Type: research